Center-Authored Papers

Filters: Author is Disis, Mary L  [Clear All Filters]
2008
Cheever MA, Schlom J, Weiner LM, Lyerly KH, Disis ML, Greenwood A, Grad O, Nelson WG.  2008.  Translational Research Working Group developmental pathway for immune response modifiers.. Clinical cancer research : an official journal of the American Association for Cancer Research. 14(18):5692-9. Abstract
2009
Coveler AL, Goodell V, Webster DJ, Salazar LG, Fintak PA, Childs JS, Higgins DM, Disis ML.  2009.  Common adjuvant breast cancer therapies do not inhibit cancer vaccine induced T cell immunity.. Breast cancer research and treatment. 113(1):95-100. Abstract
Li ZY, Liu Y, Tuve S, Xun Y, Fan X, Min L, Feng Q, Kiviat N, Kiem H-P, Disis ML et al..  2009.  Toward a stem cell gene therapy for breast cancer.. Blood. 113(22):5423-33. Abstract
Disis ML, Wallace DR, Gooley TA, Dang Y, Slota M, Lu H, Coveler AL, Childs JS, Higgins DM, Fintak PA et al..  2009.  Concurrent trastuzumab and HER2/neu-specific vaccination in patients with metastatic breast cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(28):4685-92. Abstract
2011
Paulson KG, Iyer JG, Tegeder AR, Thibodeau R, Schelter J, Koba S, Schrama D, Simonson WT, Lemos BD, Byrd DR et al..  2011.  Transcriptome-wide studies of merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(12):1539-46. Abstract
2012
Amon LM, Pitteri SJ, Li CI, McIntosh MW, Ladd J, Disis ML, Porter PL, Wong C-H, Zhang Q, Prentice RL et al..  2012.  Concordant release of glycolysis proteins into the plasma preceding a diagnosis of ER+ breast cancer.. Cancer research. Abstract
Lu H, Ladd J, Feng Z, Wu M, Goodell V, Pitteri SJ, Li CI, Prentice R, Hanash SM, Disis ML.  2012.  Evaluation of Known Oncoantibodies, HER2, p53, and Cyclin B1, in Prediagnostic Breast Cancer Sera.. Cancer prevention research (Philadelphia, Pa.). Abstract
2013
Marzbani E, Inatsuka C, Lu H, Disis ML.  2013.  The invisible arm of immunity in common cancer chemoprevention agents.. Cancer prevention research (Philadelphia, Pa.). 6(8):764-73. Abstract
Disis ML, Gad E, Herendeen DR, Lai VP-, Park KH, Cecil DL, O'Meara MM, Treuting PM, Lubet RA.  2013.  A Multiantigen Vaccine Targeting Neu, IGFBP-2, and IGF-IR Prevents Tumor Progression in Mice with Preinvasive Breast Disease.. Cancer prevention research (Philadelphia, Pa.). 6(12):1273-82. Abstract
Disis ML, Stanton SE.  2013.  Can immunity to breast cancer eliminate residual micrometastases? Clinical cancer research : an official journal of the American Association for Cancer Research. 19(23):6398-403. Abstract
Broussard EK, Kim R, Wiley JC, Marquez JP, Annis JE, Pritchard D, Disis ML.  2013.  Identification of putative immunologic targets for colon cancer prevention based on conserved gene upregulation from preinvasive to malignant lesions.. Cancer prevention research (Philadelphia, Pa.). 6(7):666-74. Abstract
Chao T, Ladd JJ, Qiu J, Johnson MM, Israel R, Chin A, Wang H, Prentice RL, Feng Z, Disis ML et al..  2013.  Proteomic profiling of the autoimmune response to breast cancer antigens uncovers a suppressive effect of hormone therapy.. Proteomics. Clinical applications. 7(5-6):327-336. Abstract
Cecil DL, Park KH, Gad E, Childs JS, Higgins DM, Plymate SR, Disis ML.  2013.  T-helper I immunity, specific for the breast cancer antigen insulin-like growth factor-I receptor (IGF-IR), is associated with increased adiposity.. Breast cancer research and treatment. 139(3):657-65. Abstract
Liao JB, Disis ML.  2013.  Therapeutic vaccines for ovarian cancer.. Gynecologic oncology. Abstract
Engel AL, Sun G-C, Gad E, Rastetter LR, Strobe K, Yang Y, Dang Y, Disis ML, Lu H.  2013.  Protein-bound polysaccharide activates dendritic cells and enhances OVA-specific T cell response as vaccine adjuvant.. Immunobiology. Abstract
Inatsuka C, Yang Y, Gad E, Rastetter L, Disis ML, Lu H.  2013.  Gamma delta T cells are activated by polysaccharide K (PSK) and contribute to the anti-tumor effect of PSK.. Cancer immunology, immunotherapy : CII. Abstract
Scott CS, Nagasawa PR, Abernethy NF, Ramsey BW, Martin PJ, Hacker BM, Schwartz HD, Brock DM, Robins LS, Wolf FM et al..  2013.  Expanding Assessments of Translational Research Programs: Supplementing Metrics With Value Judgments.. Evaluation & the health professions. Abstract
2014
Disis ML, Dang Y, Coveler AL, Marzbani E, Kou ZC, Childs JS, Fintak P, Higgins DM, Reichow J, Waisman J et al..  2014.  HER-2/neu vaccine-primed autologous T-cell infusions for the treatment of advanced stage HER-2/neu expressing cancers.. Cancer immunology, immunotherapy : CII. 63(2):101-9. Abstract
Yang Y, Inatsuka C, Gad E, Disis ML, Standish LJ, Pugh N, Pasco DS, Lu H.  2014.  Protein-bound polysaccharide-K induces IL-1β via TLR2 and NLRP3 inflammasome activation.. Innate immunity. 20(8):857-66. Abstract
Mao J, Ladd J, Gad E, Rastetter L, Johnson MM, Marzbani E, Childs JS, Lu H, Dang Y, Broussard E et al..  2014.  Mining the pre-diagnostic antibody repertoire of TgMMTV-neu mice to identify autoantibodies useful for the early detection of human breast cancer.. Journal of translational medicine. 12(1):121. Abstract
Gad E, Rastetter L, Slota M, Koehnlein M, Treuting PM, Dang Y, Stanton S, Disis ML.  2014.  Natural history of tumor growth and immune modulation in common spontaneous murine mammary tumor models.. Breast cancer research and treatment. 148(3):501-10. Abstract
Lai VP-, Kievit FM, Florczyk SJ, Wang K, Disis ML, Zhang M.  2014.  CCL21 and IFNγ Recruit and Activate Tumor Specific T cells in 3D Scaffold Model of Breast Cancer.. Anti-cancer agents in medicinal chemistry. 14(2):204-10. Abstract
Disis ML, Palucka K.  2014.  Evaluation of Cancer Immunity in Mice.. Cold Spring Harbor protocols. 2014(3):231-4. Abstract
Cecil DL, Holt GE, Park KH, Gad E, Rastetter L, Childs J, Higgins D, Disis ML.  2014.  Elimination of IL-10-Inducing T-Helper Epitopes from an IGFBP-2 Vaccine Ensures Potent Antitumor Activity.. Cancer research. 74(10):2710-8. Abstract
Paulson KG, Tegeder A, Willmes C, Iyer JG, Afanasiev OK, Schrama D, Koba S, Thibodeau R, Nagase K, Simonson WT et al..  2014.  Downregulation of MHC-I expression is prevalent but reversible in Merkel cell carcinoma.. Cancer immunology research. 2(11):1071-9. Abstract